Listeria monocytogenes peritonitis: case report and literature review

J J Sivalingam1, P Martin, H S Fraimow

  • 1Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania.

Insights

Listeria peritonitis, a rare infection in debilitated patients, often affects those with chronic liver disease. Ampicillin is recommended for treatment, avoiding cephalosporins typically used for spontaneous bacterial peritonitis.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Hepatology

Background:

  • Listeria monocytogenes is a Gram-positive bacterium causing illness in healthy and immunocompromised individuals.
  • Peritonitis is an inflammation of the peritoneum, often associated with infection.
  • Chronic liver disease, particularly cirrhosis, can predispose individuals to serious infections.

Observation:

  • This study details a case of Listeria peritonitis and cerebritis in a patient with cirrhosis.
  • A review of 11 additional cases highlights Listeria peritonitis as a rare complication in debilitated patients.
  • Commonly affected populations include those with chronic liver disease, undergoing peritoneal dialysis, or with malignancy.

Findings:

  • Listeria peritonitis presents similarly to spontaneous bacterial peritonitis, with symptoms like fever, abdominal pain, and neutrocytic ascites.
  • Bacteremia frequently accompanies Listeria peritonitis.
  • Treatment success is achievable with antimicrobial drugs, with ampicillin identified as a potential drug of choice.

Implications:

  • The findings suggest ampicillin as a preferred treatment for Listeria peritonitis, contrasting with standard spontaneous bacterial peritonitis therapies.
  • Avoidance of third-generation cephalosporins is advised in suspected Listeria peritonitis cases.
  • Early and appropriate antimicrobial therapy is crucial for managing Listeria peritonitis, especially in vulnerable patient groups.